Company: TVRD
Filing Date: 2025-11-13
Form Type: 424B3
Source: 0001104659-25-111336
Chunk: 24

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 424B3
Chunk 24
---
, 
 2025                                    
 ​                                       |   ​ | ​ | ​    
 2024 
 ​    |   ​ |
|:---------------------|:--|:-----------------------------------------|---:|:--|:-----|---:|:--|:----------------------------------------|----:|:--|:-----|----:|
| Operating lease cost | ​ | $                                        | 24 | ​ | $    | 22 | ​ | $                                       |  72 | ​ | $    |  67 |
| Variable lease cost  | ​ |                                          | 21 | ​ |      | 21 | ​ |                                         |  61 | ​ |      |  59 |
| Total lease costs    | ​ | $                                        | 45 | ​ | $    | 43 | ​ | $                                       | 133 | ​ | $    | 126 |

​

Supplemental disclosure of cash flow information
related to the lease were as follows (in thousands):

| ​                                          
 ​                                          | ​ 
 ​ | ​    
 2025 |                                        ​ 
 For the Three Months Ended September 30, | ​ | ​    
 2024 |  ​ | ​ | ​    
 2025 |                                       ​ 
 For the Nine Months Ended September 30, | ​ | ​    
 2024 |   ​ |
|:-------------------------------------------|:--|:-----|-----------------------------------------:|:--|:-----|---:|:--|:-----|----------------------------------------:|:--|:-----|----:|
| Operating cash flows from operating leases | ​ | $    |                                       50 | ​ | $    | 50 | ​ | $    |                                     150 | ​ | $    | 148 |

​

The weighted-average discount rate and remaining
lease term were as follows:

​

| ​                                     | ​ |                                        ​ | ​ |    ​ | ​ | ​ |                                       ​ | ​ |    ​ | ​ |
| ​                                     |   | For the Three Months Ended September 30, |   |      |   |   | For the Nine Months Ended September 30, |   |      |   |
| ​                                     |   |                                     2025 |   | 2024 |   |   |                                    2025 |   | 2024 |   |
| Weighted-average discount rate        |   |                                     9.50 | % | 9.50 | % |   |                                    9.50 |